Mednax Inc (MD)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -101,341 | -48,359 | 81,370 | 135,228 | 7,148 |
| Revenue | US$ in thousands | 2,012,920 | 1,994,640 | 1,972,020 | 1,911,190 | 1,733,950 |
| Pretax margin | -5.03% | -2.42% | 4.13% | 7.08% | 0.41% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $-101,341K ÷ $2,012,920K
= -5.03%
The pretax margin of Mednax Inc has varied over the past few years. In December 2020, the pretax margin was at a low of 0.41%, showing a small profitability relative to its total revenue. However, in December 2021, there was a significant improvement as the pretax margin increased to 7.08%, indicating better operational efficiency and profitability.
Subsequently, in December 2022, the pretax margin decreased to 4.13%, but still remained above the levels seen in 2020. However, there was a notable decline in performance in December 2023, with the pretax margin turning negative at -2.42%, suggesting that the company's expenses exceeded its earnings before taxes.
The trend worsened in December 2024, with the pretax margin further decreasing to -5.03%, indicating a significant loss-making situation for Mednax Inc. Overall, the fluctuating pretax margin reflects the company's changing financial performance and operational challenges over the years.
Peer comparison
Dec 31, 2024